Visit our community blood centers in Illinois, Indiana, Michigan and Wisconsin.
About Us Careers Events Customer Service Newsroom
Postdoctoral fellow Bandana Singh, PhD, believes Versiti Blood Research Institute is poised to make a big impact in the field of vascular biology.
Investigator Weiguo Cui, MD, PhD, believes T cells are the key to fighting solid tumors in cancer patients.
Associate Investigator Matthew Riese, MD, PhD, hopes to use a patient’s own immune system to fight cancer.
Genetic sequencing may be the key to innovative cancer treatment options.
Versiti Blood Research Institute supports 40 investigators whose mission it is to research all things blood.
British recently began medical school at the Medical College of Wisconsin and has a passion for providing care to patients in underserved communities.
Senior Investigator Qizhen Shi, MD, PhD, focuses on novel gene therapy.
Why it is so important to support the life-saving work being done at Versiti Blood Research Institute.
How understanding the genetics behind hemophilia A and von Willebrand disease will help inform patient treatment and develop gene therapies.
Versiti Blood Research Institute was awarded the very first grant to study HIV/AIDS benefiting hemophilia patients who require blood transfusions.
Investigators will use the funds to do specialized genetic tests of von Willebrand function and create a repository of patient samples.
Senior Investigator Bonnie Dittel, PhD, recently identified a new immune cell subset that helps to dampen autoimmune attacks.
Senior Investigator Alan Mast, MD, PhD, is studying tissue factor pathway inhibitor (TFPI) and its impact on patients with bleeding and clotting disorders.
Congratulations to Hervé Falet, PhD, and his winning photo “Platelet Fireworks,” which appeared on the cover of medical journal Platelets.
Hervé Falet, PhD, is an expert in platelet function and is investigating how they form in the bone marrow.
Dr. Pulikkan would like to develop drugs that are specially targeted to the mutated leukemia cells, so that the drugs would have no side effects.
Learning more about normal blood formation will help Associate Investigator Nan Zhu, PhD, work toward better treatments for patients with AML.
Blood Research Institute Senior Investigator Jack Gorski, PhD, is interested in learning how a universal flu vaccine would better protect people of all ages.
Blood Research Institute investigator and Medical College of Wisconsin physician Karen Carlson is looking for better ways to treat patients with acute myeloid leukemia.
The Blood Research Institute is on the cutting edge of research to determine why some patients experience severe reactions to mismatched blood types.
Thanks to the National Institutes of Health, the Blood Research Institute is continuing to advance patient care.
Read about the amazing legacy of Dr. Joan Gill.
Versiti’s Specialist in Blood Banking Program offers continuous education for blood banking professionals. Recent graduate Nichole Miller’s student project focused on red blood cell antibody testing.
Treating patients for their illnesses is one thing, but interpreting their test results is another. Our expert was called on to better understand a sickle cell patient suffering from severe anemia.
Ongoing testing and research at Versiti’s Diagnostic Laboratories will help determine the impact that prescribed medications can have on platelet counts and patient outcomes.
3-D imagery of bone marrow, created by BRI imaging expert Jon Weiser allowing for the quantification of different types of tissue by researchers.
How much post-operative bleeding is normal in babies? Blood Research Institute Investigator Debra Newman, PhD, is working hard on new research to help our tiniest patients.
For patients suffering from sickle cell disease, pain can be a daily struggle. Life-saving work at the Blood Research Institute is improving patient outlooks and quality of life.
Inherited platelet disorders (IPDs) are a heterogeneous group of conditions that can affect platelet number, platelet function, or both.
Technology allows for more precise
measurement of von Willebrand factor activity